ロード中...
The emerging role of immune checkpoint based approaches in AML and MDS
The development of immune checkpoint inhibitors represents a major breakthrough in the field of cancer therapeutics. Pursuant to their success in melanoma and numerous solid tumor malignancies, these agents are being investigated in hematological malignancies including acute myelogenous leukemia (AM...
保存先:
| 出版年: | Leuk Lymphoma |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5872841/ https://ncbi.nlm.nih.gov/pubmed/28679300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2017.1344905 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|